Clik here to view.
Study: Opioid-related deaths overwhelming intensive care units
Intensive care units in hospitals have seen a sharp increase in the number of opioid-related admissions and deaths since 2009, according to a study by researchers at Beth Israel Deaconess Medical...
View ArticleClik here to view.
BioTime lands $2m for dry-AMD therapy
BioTime Inc. (NYSE:BTX) said today that its subsidiary, Cell Cure Neurosciences, has landed a $2 million grant from the Israel Innovation Authority for the development of its dry-AMD therapy, OpRegen....
View ArticleClik here to view.
Tandem launches pivotal trial for predictive insulin pump
Tandem Diabetes Care (NSDQ:TNDM) said today that it enrolled the first patient in an at-home pivotal trial of its t:slim X2 insulin pump combined with the company’s predictive low glucose suspend...
View ArticleClik here to view.
Opthea touts data from wet-AMD trial
Opthea (ASX:OPT) touted additional data today from the Phase I/IIa trial of its wet age-related macular degeneration therapy, OPT-302. The 50-patient Phase I/IIa trial recruited participants who were...
View ArticleClik here to view.
Milestone Scientific logs Q2 beat
Injection device maker Milestone Scientific (NYSE:MLSS) topped expectations on Wall Street today with its second quarter results. The Livingston, N.J.-based company posted a net loss of -$1.5 million...
View ArticleClik here to view.
Aradigm lands NIH grant for inhaled, liposomal products
Aradigm Corp. (NSDQ:ARDM) said today that the National Institute of Allergy and Infectious Diseases and the NIH awarded the company a grant to study the treatment of pulmonary non-tuberculous...
View ArticleClik here to view.
Amneal Pharmaceuticals issues voluntary recall of lorazepam droppers
Amneal Pharmaceuticals said today that it is voluntarily recalling 13 lots of its oral lorazepam product due to a defect in the dosing dropper. In some cases, the dropper is printed with the dose...
View ArticleClik here to view.
Glytec lands another 510(k) clearance for diabetes management software
Glytec said today that it won a fourth 510(k) clearance from the FDA for its insulin titration software, eGlycemic Management System featuring Glucommander. The latest FDA nod applies to product...
View ArticleClik here to view.
Roche, Mimetas develop “gut-on-a-chip” tech for drug-testing
Mimetas said today that it collaborated with Roche (OTC:RHHBY) to develop an organ-on-a-chip system that is designed to evaluate intestinal permeability in 3D gut tubules following exposure to drug...
View ArticleClik here to view.
Study: Drug-delivery micromotors treat bacterial infection in stomach
Researchers at the University of California San Deigo have successfully used tiny micromotors loaded with antibiotics to treat a bacterial infection in the stomachs of mice, according to a study...
View ArticleClik here to view.
UPDATE: Industry panels disintegrate in wake of Trump remarks
A pair of industry panels convened by President Donald Trump disintegrated today in the wake of his latest comments on the racist violence in Charlottesville. After Merck (NYSE:MRK) CEO Kenneth...
View ArticleClik here to view.
Novo Nordisk diabetes drug succeeds in late-stage trial
Shares in Novo Nordisk (NYSE:NVO) rose nearly 5% yesterday afternoon after the insulin-maker said that its once-weekly diabetes drug, semaglutide, succeeded in lowering glucose levels in a late-stage...
View ArticleClik here to view.
Mylan inks $465m settlement with DOJ over EpiPen Medicaid classification
Mylan (NSDQ:MYL) said today that it inked a $465 million deal with U.S. Dept. of Justice to settle claims that it misclassified its EpiPen allergy auto-injector device with the Medicaid Drug Rebate...
View ArticleClik here to view.
House Dems launch MS drug pricing probe
Democrats from the House Committee on Oversight and Government Reform have sent letters to seven drugmakers as part of an investigation into why prices for multiple sclerosis drugs have nearly...
View ArticleClik here to view.
Nanotech, immunotherapy combo vaccinates mouse against cancer
Researchers from Duke University combined an FDA-approved cancer immunotherapy with gold nanostars to boost the cancer-killing abilities of both therapies, according to a study published this week in...
View ArticleClik here to view.
Drug blocked by European regulators improves quality of life for MS patients
A study by researchers at the Queen Mary University of London has found that a drug blocked by European regulators can improve the quality of life for people with multiple sclerosis. The team of...
View ArticleClik here to view.
South Carolina becomes latest state to sue opioid-maker Purdue
On Tuesday this week, South Carolina became the latest state to sue Purdue Pharma, accusing the drugmaker of deceptively marketing their addictive products in a way that fueled the ongoing opioid...
View ArticleClik here to view.
BTG helps fund immuno-oncology drug-device research programs
BTG (LON:BTG) and the Society of Interventional Oncology said today that it expanded its immuno-oncology/interventional oncology research grant program. The group launched a second round of funding,...
View ArticleClik here to view.
Researchers progress towards vaccine against fentanyl, heroin combo
Researchers reported at the 254th National Meeting & Exposition of the American Chemical Society today that they are developing a vaccine to guard against the effects of fentanyl in combination...
View ArticleClik here to view.
Tool identifies diabetes patients at risk for severe hypoglycemia
Researchers have developed a tool used to identify diabetes patients who are at-risk for being admitted to the hospital due to severe hypoglycemia, according to a study published today in JAMA Internal...
View Article